LINC00400

Across TCGA pan-cancer cohorts, LINC00400 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC00400 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00400 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00400 expression acts as an unfavorable survival marker, although some lineages such as BLCA and ACC show a favorable association.

LUAD, READ, and UCS are the cancer types where LINC00400 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	78	view →
READ	DFS	Tertile	III,IV	0.222	0.765	.001	57	view →
UCS	DFS	Tertile	III,IV	0.178	0.469	.019	54	view →
COAD	DFS	Tertile	All	0.284	0.706	<.001	48	view →
BLCA	DFS	Tertile	III,IV	0.882	0.426	.021	42	view →
STAD	DFS	Tertile	All	0.383	0.570	.003	39	view →
MESO	OS	Tertile	IV	0.036	0.602	<.001	36	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
LIHC	OS	Tertile	II,III,IV	0.163	0.719	<.001	36	view →
UCEC	OS	Tertile	All	0.836	0.933	<.001	36	view →
THCA	OS	Tertile	All	0.539	0.958	<.001	33	view →
PRAD	DFS	Tertile	All	0.736	0.890	.009	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC00400–LUAD (DFS)

Open the LUAD breakdown →